NTC
North Tide Capital Portfolio holdings
AUM
$469M
1-Year Return
6.55%
This Quarter Return
+8.75%
1 Year Return
+6.55%
3 Year Return
+14.78%
5 Year Return
–
10 Year Return
–
AUM
$1.43B
AUM Growth
+$243M
(+20%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
9.09%
Top 10 Holdings %
Top 10 Hldgs %
63.17%
Holding
29
New
5
Increased
9
Reduced
3
Closed
3
Top Buys
| 1 |
Bausch Health
BHC
|
$63.1M |
| 2 |
SVU
SUPERVALU Inc.
SVU
|
$53.4M |
| 3 |
Edwards Lifesciences
EW
|
$51.5M |
| 4 |
VVUS
Vivus Inc
VVUS
|
$47.9M |
| 5 |
Boston Scientific
BSX
|
$43.4M |
Top Sells
| 1 |
AGN
ALLERGAN INC
AGN
|
$84.6M |
| 2 |
AGN
Allergan plc
AGN
|
$82.3M |
| 3 |
Elevance Health
ELV
|
$26.9M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$26.1M |
| 5 |
Viatris
VTRS
|
$24.4M |
Sector Composition
| 1 | Healthcare | 82.38% |
| 2 | Consumer Discretionary | 4.51% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GHDX
26
DELISTED
Genomic Health, Inc.
GHDX
| $8.22M | 0.57% |
300,000
+200,000
| +200% | +$5.48M |
|
|
27
Viatris
VTRS
$12.2B
| – | – |
-500,000
| Closed | -$24.4M |
|
|
AGN
28
DELISTED
Allergan plc
AGN
| – | – |
-400,000
| Closed | -$82.3M |
|
|
AH
29
DELISTED
ACCRETIVE HEALTH, INC COMMON STOCK
AH
| – | – |
-2,000,000
| Closed | -$16M |
|